Komplementarselskabet af 30/9 2025 ApS: Financial statements 2022
CVR: 42496499
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Komplementarselskabet af 30/9 2025 ApS (CVR 42496499) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -5,000 and a net result of DKK 0. Equity in the 2022 report amounted to DKK 33,970. The solvency ratio was 87.2%. The company had 2 employees in the financial year.
- Gross Profit
- DKK -5,000
- Profit/Loss
- DKK 0
- Equity
- DKK 33,970
- Total Assets
- DKK 38,970
- Employees
- 2
Official annual report
Keep an eye on Komplementarselskabet af 30/9 2025 ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Komplementarselskabet af 30/9 2025 ApS has published its interim report for the period June 16, 2021 to December 31, 2021.
As of June 20, 2022, A/S PSE 17 NR. 1056 has stepped down as auditor of Komplementarselskabet af 30/9 2025 ApS.
As of May 9, 2022, A/S PSE 17 NR. 1056 has been appointed auditor of Komplementarselskabet af 30/9 2025 ApS.
As of May 9, 2022, EMIT P/S has stepped down as auditor of Komplementarselskabet af 30/9 2025 ApS.
About Komplementarselskabet af 30/9 2025 ApS
Komplementarselskabet af 30/9 2025 ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2021. The company is under bankruptcy. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named Komplementarselskabet Surgiteam ApS. The company is owned by Ortkirlaeger ApS and Ortoflex Holding ApS. According to the 2024 annual report, the company had an average of 2 employees. In 2024, the company reported a gross profit of DKK -5,000 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2024 report amounted to DKK 33,970.
